Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Translational Oncology|January 4, 2020
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse ModelKentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Oncotarget|October 6, 2017
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncologyKentaro Igarashi, Takashi Murakami, Kei Kawaguchi, et al.
Oncology Letters|May 8, 2023
A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcomaYoshihiro Araki, Naofumi Asano, Norio Yamamoto, et al.
Anticancer Research|November 29, 2025
Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine DietYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 29, 2025
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old PatientYohei Asano, Toshihiko Sato, Chihiro Hozumi, et al.
Oncotarget|October 4, 2017
A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Tissue & Cell|May 29, 2019
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse modelsKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Tissue & Cell|August 1, 2018
Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse modelTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
Cell Cycle (Georgetown, Tex.)|January 16, 2018
Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse modelKentaro Miyake, Kei Kawaguchi, Tasuku Kiyuna, et al.
Pageof 24